HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Hans Gelderblom Selected Research

cremophor EL

5/2009Multiple-pool cell lifespan models for neutropenia to assess the population pharmacodynamics of unbound paclitaxel from two formulations in cancer patients.
7/2005Association of Paclitaxel pharmacokinetics with the development of peripheral neuropathy in patients with advanced cancer.
6/2003Distribution of paclitaxel in plasma and cerebrospinal fluid.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Hans Gelderblom Research Topics

Disease

52Neoplasms (Cancer)
12/2015 - 01/2002
18Colorectal Neoplasms (Colorectal Cancer)
09/2015 - 01/2009
16Sarcoma (Soft Tissue Sarcoma)
12/2015 - 07/2008
11Osteosarcoma (Osteogenic Sarcoma)
08/2015 - 04/2011
8Neoplasm Metastasis (Metastasis)
07/2015 - 09/2005
8Breast Neoplasms (Breast Cancer)
04/2014 - 06/2003
6Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
08/2015 - 07/2008
5Renal Cell Carcinoma (Grawitz Tumor)
12/2015 - 02/2011
4Prostatic Neoplasms (Prostate Cancer)
03/2015 - 05/2013
4Adrenocortical Carcinoma
02/2015 - 04/2011
4Neutropenia
04/2014 - 11/2008
4Nausea
05/2012 - 02/2011
3Hypertension (High Blood Pressure)
12/2015 - 06/2008
3Disease Progression
07/2015 - 01/2013
3Chondrosarcoma
10/2014 - 03/2008
3Vomiting
01/2012 - 02/2011
2Leukopenia
12/2015 - 09/2009
2Giant Cell Tumors (Giant Cell Tumor)
06/2015 - 03/2012
2Thrombocytopenia (Thrombopenia)
04/2014 - 09/2009
2Stomatitis
12/2013 - 01/2012
2Fatigue
05/2012 - 09/2003
2Thyroid Neoplasms (Thyroid Cancer)
08/2010 - 12/2009
2Inflammation
09/2009 - 12/2004
2Peripheral Nervous System Diseases (PNS Diseases)
07/2005 - 01/2002
1Aggressive Fibromatosis (Desmoid)
12/2015
1Fibroma (Fibromatosis)
12/2015
1Agranulocytosis (Granulocytopenia)
08/2015
1Cushing Syndrome
04/2014

Drug/Important Bio-Agent (IBA)

12Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2015 - 02/2007
9imatinib (Gleevec)FDA Link
12/2015 - 12/2007
9sunitinib (Sutent)FDA Link
12/2015 - 09/2009
7Cisplatin (Platino)FDA LinkGeneric
07/2015 - 04/2011
6Doxorubicin (Adriamycin)FDA LinkGeneric
11/2015 - 03/2012
6irinotecan (Camptosar)FDA LinkGeneric
09/2015 - 11/2005
6cetuximab (Erbitux)FDA Link
01/2015 - 07/2010
6Epidermal Growth Factor Receptor (EGF Receptor)IBA
12/2013 - 01/2011
6Paclitaxel (Taxol)FDA LinkGeneric
12/2013 - 01/2002
5oxaliplatin (Eloxatin)FDA LinkGeneric
09/2015 - 03/2009
4capecitabine (Xeloda)FDA Link
07/2015 - 03/2009
4Mitotane (Lysodren)FDA Link
02/2015 - 04/2011
4pazopanibIBA
01/2015 - 01/2012
4Cytochrome P-450 CYP2D6 (CYP2D6)IBA
01/2014 - 01/2009
3IfosfamideFDA LinkGeneric
11/2015 - 01/2014
3bevacizumabFDA Link
01/2015 - 01/2009
3Melphalan (Alkeran)FDA LinkGeneric
10/2014 - 07/2008
3exemestane (Aromasin)FDA Link
04/2014 - 07/2011
3TamoxifenFDA LinkGeneric
01/2014 - 01/2009
3sorafenib (BAY 43-9006)FDA Link
01/2012 - 12/2009
3telatinibIBA
02/2011 - 06/2008
3cremophor ELIBA
05/2009 - 06/2003
3BN 80915IBA
01/2009 - 09/2003
2UracilIBA
07/2015 - 07/2015
24- acetoxy- 13- ((3- ((tert- butoxycarbonyl)amino)- 2- hydroxy- 3- phenylpropanoyl)oxy)- 1- hydroxy- 7,10- dimethoxy- 9- oxo- 5,20- epoxytax- 11- en- 2- yl benzoateFDA Link
03/2015 - 09/2013
2docetaxel (Taxotere)FDA Link
03/2015 - 09/2014
2LBH589IBA
01/2015 - 11/2014
2Etoposide (VP 16)FDA LinkGeneric
01/2015 - 06/2012
2Biological Markers (Surrogate Marker)IBA
09/2014 - 09/2005
2HormonesIBA
04/2014 - 08/2010
2Estrogens (Estrogen)FDA Link
01/2014 - 07/2011
2DNA (Deoxyribonucleic Acid)IBA
12/2013 - 01/2009
2Sirolimus (Rapamycin)FDA Link
12/2013 - 01/2012
2Liposomes (Liposome)IBA
12/2013 - 02/2012
2InterferonsIBA
04/2013 - 06/2012
2CamptothecinIBA
06/2012 - 09/2003
2AntiemeticsIBA
01/2012 - 10/2011
2LigandsIBA
04/2011 - 09/2008
2Natural Killer Cell ReceptorsIBA
04/2011 - 09/2008
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
02/2011 - 09/2009
2Phosphotransferases (Kinase)IBA
12/2009 - 02/2007
2Tyrosine (L-Tyrosine)FDA Link
12/2009 - 02/2007
2Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
09/2009 - 06/2008
1Interleukin-13IBA
12/2015
1Interleukin-8 (Interleukin 8)IBA
12/2015
1Vincristine (Oncovin)FDA LinkGeneric
11/2015
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2015
1panitumumab (Vectibix)FDA Link
09/2015
1Simvastatin (Zocor)FDA LinkGeneric
09/2015
1Prednisolone (Predate)FDA LinkGeneric
08/2015
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
08/2015
1First StepIBA
08/2015
1Methotrexate (Mexate)FDA LinkGeneric
07/2015
1peginterferon alfa-2b (Pegintron)FDA Link
07/2015
1TegafurIBA
07/2015
1Leucovorin (Folinic Acid)FDA Link
07/2015
1denosumabFDA Link
06/2015
1abirateroneIBA
03/2015
1Carboplatin (JM8)FDA LinkGeneric
01/2015
1N 30IBA
10/2014
1KinesinIBA
09/2014
1Antineoplastic Agents (Antineoplastics)IBA
07/2014
1pegfilgrastim (Neulasta)FDA Link
04/2014
1Hydrocortisone (Cortisol)FDA LinkGeneric
04/2014
1Mesna (Coenzyme M)FDA LinkGeneric
04/2014

Therapy/Procedure

24Drug Therapy (Chemotherapy)
11/2015 - 03/2008
6Radiotherapy
12/2015 - 03/2008
3Aftercare (After-Treatment)
01/2014 - 09/2005
3Adjuvant Chemotherapy
09/2012 - 02/2010
3Combination Drug Therapy (Combination Chemotherapy)
06/2012 - 11/2008
2Intravenous Infusions
04/2014 - 01/2002
1Individualized Medicine
08/2015